Cargando…

Perioperative acute kidney injury

Acute kidney injury (AKI) is a serious complication in the perioperative period, and is consistently associated with increased rates of mortality and morbidity. Two major consensus definitions have been developed in the last decade that allow for easier comparison of trial evidence. Risk factors hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvert, Stacey, Shaw, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886265/
https://www.ncbi.nlm.nih.gov/pubmed/24764522
http://dx.doi.org/10.1186/2047-0525-1-6
_version_ 1782478878454841344
author Calvert, Stacey
Shaw, Andrew
author_facet Calvert, Stacey
Shaw, Andrew
author_sort Calvert, Stacey
collection PubMed
description Acute kidney injury (AKI) is a serious complication in the perioperative period, and is consistently associated with increased rates of mortality and morbidity. Two major consensus definitions have been developed in the last decade that allow for easier comparison of trial evidence. Risk factors have been identified in both cardiac and general surgery and there is an evolving role for novel biomarkers. Despite this, there has been no real change in outcomes and the mainstay of treatment remains preventive with no clear evidence supporting any therapeutic intervention as yet. This review focuses on definition, risk factors, the emerging role of biomarkers and subsequent management of AKI in the perioperative period, taking into account new and emerging strategies.
format Online
Article
Text
id pubmed-3886265
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38862652014-01-13 Perioperative acute kidney injury Calvert, Stacey Shaw, Andrew Perioper Med (Lond) Review Acute kidney injury (AKI) is a serious complication in the perioperative period, and is consistently associated with increased rates of mortality and morbidity. Two major consensus definitions have been developed in the last decade that allow for easier comparison of trial evidence. Risk factors have been identified in both cardiac and general surgery and there is an evolving role for novel biomarkers. Despite this, there has been no real change in outcomes and the mainstay of treatment remains preventive with no clear evidence supporting any therapeutic intervention as yet. This review focuses on definition, risk factors, the emerging role of biomarkers and subsequent management of AKI in the perioperative period, taking into account new and emerging strategies. BioMed Central 2012-07-04 /pmc/articles/PMC3886265/ /pubmed/24764522 http://dx.doi.org/10.1186/2047-0525-1-6 Text en Copyright © 2012 Calvert and Shaw; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Calvert, Stacey
Shaw, Andrew
Perioperative acute kidney injury
title Perioperative acute kidney injury
title_full Perioperative acute kidney injury
title_fullStr Perioperative acute kidney injury
title_full_unstemmed Perioperative acute kidney injury
title_short Perioperative acute kidney injury
title_sort perioperative acute kidney injury
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886265/
https://www.ncbi.nlm.nih.gov/pubmed/24764522
http://dx.doi.org/10.1186/2047-0525-1-6
work_keys_str_mv AT calvertstacey perioperativeacutekidneyinjury
AT shawandrew perioperativeacutekidneyinjury